Smart Pill-Bottle Technology on Medication Adherence Case Study

Medication non-adherence with complex oral oncolytic regimens that patients take from home can lead to ineffective treatments, hospitalizations, and unnecessary disease progression. This case study covers:

• Primary and secondary objectives of the study
• Patient inclusion criteria and methods for collecting data
• Results and reasons for discontinuation
• Secondary results and significance of real-time interventions
• Overall study conclusions

DOWNLOAD

Avella SMS Case Study

Influence of SMS Adherence in Specialty Population Including:

• Objective
• Short Message Service (SMS)
• Hypothesis
• Method 
• Study Results

DOWNLOAD

Avella Adherence Case Study

Improving Outcomes of Renal Transplant Recipients with Behavioral Adherence Contracts.  Case study includes:

• Research Study Objective
• Hypothesis
• Adherence "Toolkit" Utilized
• Study Results
• Conclusion

DOWNLOAD

Avella GlowCap Case Study

Patient Adherence Comparison of Avella GlowCap® Users vs. Non-users Including: 

• Disease State
• Treatment Option
• Adherence Tool
• Non-Adherence Costs
• Case Results

DOWNLOAD

Avella Sprycel Case Study: Mid-therapy Invervention

A Ph+ CML Patient Case Study Including:

• Disease State
• Treatment Options
• Adverse Event
• Mid-therapy Activity

DOWNLOAD

Medication Management Text Program for Patients

Free, interactive program from CareSpeak Communications helps patients stay on track

• Medication dosing and refill reminders
• Weekly feedback on progress toward goals for taking medication correctly (for daily or weekly therapies)
• Optional alerts for caregivers, after opt-in
• Monthly nutrition information, inspirational quotes and more
• Applies for patients in most therapies, visit the CareSpeak page for a complete list of covered therapies

LEARN MORE

Oncology Medication Mobile App

Get the latest information for prescribing oncology medications available at Avella - right from your phone. Mobile app features include:

• Search by medication or disease state for 70+ medications used to treat solid and liquid tumors (including many limited-distribution drugs)
• Learn more about the medication indication and formulation/MOA
• Review dosage and FDA indication
• Stay updated on monitoring parameters and key counseling points for each medication
• Download referral forms
• Connect with your local Avella account manager
• Sign up for the online provider portal

LEARN MORE & DOWNLOAD

Hepatitis C Medication Mobile App 

Get the latest information for prescribing hepatitis C medications available at Avella - right from your phone. Medications include:

• Daklinza™
• Harvoni®
• Olysio®
• Sovaldi®
• Technivie™
• Viekira Pak™
• Zepatier™

LEARN MORE & DOWNLOAD

Pain & Addiction Mobile App 

Get the latest information for prescribing pain and addiction management medications - right from your phone. App features include:

• More than 45 pain and addiction management medications, searchable by name or category
• Medication information such as indication, dosage, adverse reactions, warnings, contraindications and more
• Prescribing guidelines from the CDC
• Professional organizations, conferences and continuing medical education information

LEARN MORE & DOWNLOAD

Mobile HIV Treatment Resources Tool

In partnership with Guideline Central™, Avella sponsored a FREE mobile app offering HIV quick-reference guidelines for healthcare professionals including:

• What to Start: Initial Combination Regimens for the Antiretroviral-Naive Patient
• Recommended and Alternative Initial ART Regimen Options
• Advantages and Disadvantages of Antiretroviral Components
• Co-Receptor Tropism Assays
• Laboratory Monitoring Schedule for HIV-Infected Patients
• Renal and Hepatic Dosing
• Coformulated Antiretroviral Regimens
• Commonly Used Antiretroviral Agents

DOWNLOAD

Outlook on Oncology White Paper

Learn how providers, payers and specialty pharmacies are exploring new ways to optimize cancer care. This white paper covers:

• Cost and quality trends related to cancer care
• How rapid-pace oncology breakthroughs are making waves
• Specialty pharmacies' position at the center of these transformative forces
• How patient education and engagement, physician collaboration and a focus on adherence help drive down costs

DOWNLOAD

Perspectives on Pain Management White Paper

Learn how clinicians and specialty pharmacies are teaming up to provide safe, effective and appropriate pain management while minimizing patient risk. This white paper covers:

• The opioid epidemic and efforts to curb opioid abuse and prescribing
• Physicians' complex, high-risk prescribing environment
• How specialty pharmacies play a role on the pain management patient's care team
• Rigorous quality and safety standards being deployed to safeguard patients while treating pain and preventing opioid misuse

DOWNLOAD

Latex Free Claims White Paper

Learn about the risks associated with latex allergies and latex in healthcare. This white paper covers:

• The use of latex in healthcare settings and everyday life
• How latex allergies are identified and classified 
• Varying patient reactions to latex
• How unclear labeling practices can create confusion and risk

DOWNLOAD

"Performance Based" DIR Fees

A white paper covering direct and indirect remuneration, or "DIR" fees, which are charged to pharmacies by Pharmacy Benefit Managers (PBMs), and are causing a dramatic and negative impact to specialty pharmacies and the patients they serve. This paper details:

• How criteria for assessing DIR fees is ill-fit for specialty pharmacies
• How specialty pharmacies' ability to care for vulnerable patients with complex medications is at risk due to these fees
• How exceptionally expensive medication costs are being shifted to patients as a result of DIR fees
• How the US healthcare system and government are also bearing the burden of these fees

DOWNLOAD

HCV Reference Chart

This exclusive downloadable reference chart provides a resource for prescribing the latest hepatitis C medications.

This chart includes reference information for prescribers such as: 

• Treatment History
• Dose
• Duration
• Response Guided Therapy
• Sustained Virologic Response Rate

DOWNLOAD

Oral Chemotherapy Counseling Chart

This downloadable reference tool includes:

• Approved medications & indications
• Medication
• Dose
• Monitoring Parameters
• Key Counseling Points

DOWNLOAD

Hepatitis Guide

• Specialty pharmacy accreditations
• Delivery and pharmacy location options for patients
• Specialty medication therapy management to increase adherence
• Financial assistance for hepatitis C patients

DOWNLOAD

Fertility Guide

Top 5 considerations for patients and providers when choosing a specialty pharmacy.  Some questions include:

• What pharmacy capabilities are important?
• What value can specialty pharmacies offer you?
• How can a pharmacy help to contain patient costs?

DOWNLOAD

cGMP White Paper

Download our guide which provides an overview of these legislative changes and examines their potential impact on ophthalmology practices and patients including:

• A visual timeline of legislative oversight
• The history of legislative oversight in the compounding industry
• Introduction of the Drug Quality and Security Act
• Putting best practices into action

DOWNLOAD

Dispensing Excellence: Oncology Edition

Highlights in this Issue:

• In-depth Oral Chemotherapy Monitoring & Counseling Reference Chart
• Information on 75+ medications for treatment of solid and liquid tumors including many limited distribution drugs
• Prescribing informaton including: Dose/FDA Indication, Formulation, Mechanism of Action, Monitoring Parameters and Key Counseling Points
• Download information for Avella's Oral Oncology Medication Guide mobile app

DOWNLOAD

Dispensing Excellence: Summer 2015

Highlights in this Issue:

• Prior Authorizations: A Payer's "Behind-the-Scenes" Look
• Ask the Pharmacist: Polycystic Ovarian Syndrome and Infertility
• Improving Medication Adherence in HIV Patients Using Mobile Health Tools
• 340B: Reducing Costs for Outpatient Drugs
• Making a Positive Difference for Our Patients: Survey Results
• Protecting Your Practice from Data Breaches

DOWNLOAD

T790M Mutation Video

If you or a loved one has been diagnosed with EGFR+ non-small cell lung cancer, you may be at risk of developing the T790M mutation. Avella's short, informational video will help you:

• Understand what a gene mutation is
• Determine if you are at risk for the T790M mutation
• Know the right questions to ask your doctor about the T790M test

WATCH

Urology Webinar

Further understand the utilization of Enzalutamide in metastatic prostate cancer and the prostate cancer patient journey with a specialty pharmacy. 

WATCH